Back to search

Article

Efficacy and Safety of Oral Gene III <sup>®</sup> L-Ergothioneine Capsules in Primary Dysmenorrhea: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

2026-03-27

Abstract excerpt

<h4>Purpose</h4> To evaluate the efficacy and safety of oral L-ergothioneine (EGT) in alleviating pain and associated symptoms in women with primary dysmenorrhea (PD). <h4>Methods</h4> In this randomized, double-blind, placebo-controlled trial, 40 women with PD (aged 18–30 years) were randomized (1:1) to receive EGT capsules (120 mg/day) or a matching placebo for 3 consecutive menstrual cycles. Outcomes evaluate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bfa1ad11-dbd1-54be-a1c9-ab0ea20aa9dc
DOI
10.64898/2026.03.26.26349375
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy and Safety of Oral Gene III <sup>®</sup> L-Ergothioneine Capsules in Primary Dysmenorrhea: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialDOI 10.64898/2026.03.26.26349375
Select a neighboring publication to make it the new centre.